Pharmacological inhibition of SphK prevented the infection-induced reduction in P-gp activity, and notably, SphK inhibition in uninfected cells decreased R123 accumulation by about 30%, suggesting increased P-gp activity when S1P synthesis is blocked in BECs. The gene discussed is SPHK1; the disease is infection.